Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the revision history.
    Difference
    0.0%
    Check dated 2026-04-17T02:47:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Location name updated from Padua to Padova for the Veneto, Italy site (35128).
    Difference
    0.0%
    Check dated 2026-04-09T21:43:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 with the v3.4.3 label removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:26:01.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision labels updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:32:37.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the site, and the previous funding-status notice (v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:25:01.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    New site-wide notice about lapse in government funding and NIH Clinical Center operations is now visible, and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:30:25.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.